Correction to: Intraperitoneal mitomycin C improves survival compared to cytoreductive surgery alone in an experimental model of highgrade pseudomyxoma peritonei

Clin Exp Metastasis. 2021 Apr;38(2):253. doi: 10.1007/s10585-021-10084-0.

Olaf Sørensen^{1

2}, Anders Mikal Andersen³, Stein Gunnar Larsen¹, Karl-Erik Giercksky^{1

2}, Kjersti Flatmark^{4

5

6}

¹ Department of Gastroenterological Surgery, Norwegian Radium Hospital, Oslo University Hospital, Montebello, 0310, Oslo, Norway.
² Norwegian Radium Hospital, Oslo University Hospital, University of Oslo, Montebello, 0310, Oslo, Norway.
³ Department of Pharmacology, Norwegian Radium Hospital, Oslo University Hospital, Montebello, 0310, Oslo, Norway.
⁴ Department of Gastroenterological Surgery, Norwegian Radium Hospital, Oslo University Hospital, Montebello, 0310, Oslo, Norway. kjersti.flatmark@rr-research.no.
⁵ Department of Tumor Biology, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Montebello, 0310, Oslo, Norway. kjersti.flatmark@rr-research.no.
⁶ Norwegian Radium Hospital, Oslo University Hospital, University of Oslo, Montebello, 0310, Oslo, Norway. kjersti.flatmark@rr-research.no.

No abstract available

Publication types